254 related articles for article (PubMed ID: 16675902)
21. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
[TBL] [Abstract][Full Text] [Related]
22. Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemes.
Pentheroudakis G; Briasoulis E; Karavassilis V; Mauri D; Tzamakou E; Rammou D; Pavlidis N
Chemotherapy; 2005 May; 51(2-3):154-61. PubMed ID: 15886476
[TBL] [Abstract][Full Text] [Related]
23. Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer.
Tung N; Berkowitz R; Matulonis U; Quartulli M; Seiden M; Kim Y; Niloff J; Cannistra SA
Gynecol Oncol; 2000 May; 77(2):271-7. PubMed ID: 10785477
[TBL] [Abstract][Full Text] [Related]
24. CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer.
Borg C; Ray-Coquard I; Philip I; Clapisson G; Bendriss-Vermare N; Menetrier-Caux C; Sebban C; Biron P; Blay JY
Cancer; 2004 Dec; 101(11):2675-80. PubMed ID: 15503313
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
Aquino VM; Herrera L; Sandler ES; Buchanan GR
Cancer; 2000 Apr; 88(7):1710-4. PubMed ID: 10738231
[TBL] [Abstract][Full Text] [Related]
26. [Chemotherapy-induced febrile neutropenia: about 200 episodes. Clinical, microbiological and therapeutic characteristics].
Gharbi O; Ben Hadj Hassen S; Kaabia N; Limam S; Hadj Amor M; Ben Fatma L; Landolsi A; Hochlef M; Letaief A; Boukadida J; Ben Ahmed S
Pathol Biol (Paris); 2008 May; 56(3):154-7. PubMed ID: 18178025
[TBL] [Abstract][Full Text] [Related]
27. Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
Harter C; Schulze B; Goldschmidt H; Benner A; Geiss HK; Hoppe-Tichy T; Ho AD; Egerer G
Bone Marrow Transplant; 2006 Feb; 37(4):373-9. PubMed ID: 16400334
[TBL] [Abstract][Full Text] [Related]
28. Granulocytic growth factors and cancer-related neutropenia: limited effects.
Prescrire Int; 2006 Oct; 15(85):189-91. PubMed ID: 17128529
[TBL] [Abstract][Full Text] [Related]
29. Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study.
García-Sáenz JA; Martín M; Casado A; Pérez-Segura P; Manrique I; Flores L; Macias JA; Cámara JC; Perezagua C; Díaz-Rubio E
Rev Esp Quimioter; 2002 Sep; 15(3):257-63. PubMed ID: 12582429
[TBL] [Abstract][Full Text] [Related]
30. Activity and safety of epirubicin plus paclitaxel in advanced breast cancer.
Conte PF; Michelotti A; Baldini E; Tibaldi C; DaPrato M; Salvadori B; Giannessi PG; Gentile A; Biadi O; Mariani M
Semin Oncol; 1996 Feb; 23(1 Suppl 1):28-32. PubMed ID: 8629033
[TBL] [Abstract][Full Text] [Related]
31. Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia.
Jimeno A; Arcediano A; Bazares S; Amador ML; González-Cortijo L; Ciruelos E; Robles L; Castellano D; Paz-Ares L; Lumbreras C; Hornedo J; Cortés-Funes H
Clin Transl Oncol; 2006 Dec; 8(12):889-95. PubMed ID: 17169762
[TBL] [Abstract][Full Text] [Related]
32. Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.
Chuang YY; Hung IJ; Yang CP; Jaing TH; Lin TY; Huang YC
Pediatr Infect Dis J; 2002 Mar; 21(3):203-9. PubMed ID: 12005083
[TBL] [Abstract][Full Text] [Related]
33. Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules.
Rolston KV; Manzullo EF; Elting LS; Frisbee-Hume SE; McMahon L; Theriault RL; Patel S; Benjamin RS
Cancer; 2006 Jun; 106(11):2489-94. PubMed ID: 16628654
[TBL] [Abstract][Full Text] [Related]
34. Comparison of meropenem with ceftazidime as monotherapy of cancer patients with chemotherapy induced febrile neutropenia.
Malik I; Shaharyar
J Pak Med Assoc; 2002 Jan; 52(1):15-8. PubMed ID: 11963577
[TBL] [Abstract][Full Text] [Related]
35. The safety of full-dose chemotherapy with secondary prophylactic granulocyte colony stimulating factor (G-CSF) following a prior cycle with febrile neutropenia.
Haim N; Shulman K; Goldberg H; Tsalic M
Med Oncol; 2005; 22(3):229-32. PubMed ID: 16110133
[TBL] [Abstract][Full Text] [Related]
36. Low-dose continuous-infusion ceftazidime monotherapy in low-risk febrile neutropenic patients.
Marshall E; Smith DB; O'Reilly SM; Murray A; Kelly V; Clark PI
Support Care Cancer; 2000 May; 8(3):198-202. PubMed ID: 10789960
[TBL] [Abstract][Full Text] [Related]
37. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
Mustafa MM; Carlson L; Tkaczewski I; McCracken GH; Buchanan GR
Pediatr Infect Dis J; 2001 Mar; 20(3):362-9. PubMed ID: 11303851
[TBL] [Abstract][Full Text] [Related]
38. Management of febrile neutropenia in patients receiving chemotherapy for solid tumors: a retrospective study of twenty cases from the radiotherapy centre, Accra, Ghana.
Vanderpuye V; Yarney J; Beecham K
West Afr J Med; 2010; 29(5):303-8. PubMed ID: 21089015
[TBL] [Abstract][Full Text] [Related]
39. Outcome of febrile neutropenic patients on granulocyte colony stimulating factor in a tertiary care hospital.
Osmani AH; Ansari TZ; Masood N; Ahmed B
Asian Pac J Cancer Prev; 2012; 13(6):2523-6. PubMed ID: 22938399
[TBL] [Abstract][Full Text] [Related]
40. Elderly haematological patients with chemotherapy-induced febrile neutropenia have similar rates of infection and outcome to younger adults: a prospective study of risk-adapted therapy.
García-Suárez J; Krsnik I; Reyes E; De Miguel D; Hernanz N; Barr-Alí M; Burgaleta C
Br J Haematol; 2003 Jan; 120(2):209-16. PubMed ID: 12542477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
